Journal of Craniomaxillofacial Research 2016. 3(4):241-247.

A comparative evaluation of outcomes between tongue SCC and ACC of salivary glands: retrospective match-case study
Fereydoun Pourdanesh, Sahar Masoudi, Mohammad Esmaeelinejad, Reza Tabrizi


Introduction: The aim of this study was to assess Tongue Squamous Cell Carcinoma (TSCC) patients’ outcome and compare that to their matched pair counterparts of salivary gland adenoid cystic carcinoma (SGACC) patients.
Materials and Methods: A population-based cohort study was conducted using SEER data. From a database of 2019 patients, treated from 2004 to 2012. We matched individuals with
tongue SCC to those who have ACC of salivary gland. Matches were made for gender, age and treatment modalities. We compared their 5-year survival, rate of local, regional and distant failures.
Results: We identified 1716 patients with TSCC and 313 cases with SGACC. Median follow up time was 2.07 years. The frequency of SGACC was significantly high in female likewise the frequency
of TSCC in males (p≤0.001). SGACC tumor was more likely to be detected at an advanced stage (p≤0.001). The most often affected subsites in the TSCC tumor were the tongue (C02.9)
(24.5%) and in SGACC tumor were the minor salivary gland (42.5%). There was a significant (P≤0.001) difference in overall survival in favor of female with SGACC and the combined-therapy
group over the TSCC patients belong to the same group. The Kaplan–Meier estimates of overall survival at five years were 58% in the TSCC patients and 87% in the SGACC group.
Conclusion: It is important for the clinicians be aware of the invasive nature of oral malignancies especially TSCC and SGACC. These lesions are associated with high recurrence rate and distant metastasis and poor prognosis. Early detection may enhance the survival rate of the patients. The overall survival is lower in TSCC than SGACC and the death rate is higher in these kinds of tumors.
Key words: Diagnostics, Salivary glands, Cancer and pre-cancer, Squamous cell carcinoma.


Diagnostics; Salivary glands; Cancer and pre-cancer; Squamous cell carcinoma

Full Text:



Siegel R, Naishadham D, Jemal A. Cancer statis- tics, 2013. CA: a cancer journal for clinicians.2013;63(1):11-30.

] Bethesda M. SEER Cancer Statistics Factsheets: Oral Cavity and Pharynx Cancer. http://seer.can- National Can- cer Institute; [10-may-2015].

Bradley S. Oral Squamous Cell Carcinoma. http:// and-throat-disorders/tumors-of-the-head-and- neck/oral-squamous-cell-carcinoma: Merck; [10- may-2015].

Rusthoven KE, Raben D, Song JI, Kane M, Altoos TA, Chen C. Survival and patterns of relapse in patients with oral tongue cancer. Journal of Oral and Maxillofacial Surgery. 2010;68(3):584-9.

McDowell L, Collins M, Kleid S, Rischin D, Cor- ry J. T4 squamous cell carcinoma of the oral tongue without mandibular involvement: sur- gery or chemoradiotherapy? Oral surgery, oral medicine, oral pathology and oral radiology.2014;117(2):163-9.

Gosselin E. Malignant Tumors of the Mobile Tongue author. Medscape. June 2011.

Fordice, Jim; Kershaw, Corey; El-Naggar, Adel; Goepfert, Helmuth (February 1999). “Adenoid Cystic Carcinoma of the Head and Neck: Pre-dictors of Morbidity and Mortality”. Archives of Otolaryngology--Head & Neck Surgery 125 (2):149–52.

Ciccolallo L, Licitra L, Cantú G, Gatta G, Group EW. Survival from salivary glands adenoid cystic carcinoma in European populations. Oral oncolo- gy. 2009;45(8):669-74.

Shen C, Xu T, Huang C, Hu C, He S. Treatment outcomes and prognostic features in adenoid cys- tic carcinoma originated from the head and neck. Oral oncology. 2012; 48(5):445-9.

Editor Board. Salivary Gland Cancer: Statistics. American Society of Clinical On- cology 2005-2015 [10-may-2015].

Surveillance, Epidemiology, and End Results (SEER) Program ( SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2014 Sub (1973-2012) - Linked To County Attributes - Total U.S. 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission.

Surveillance Research Program, National Cancer Institute SEER * Stat software ( seerstat) version 8.2.1.

Polanska H, Raudenska M, Gumulec J, Sztalma- chova M, Adam V, Kizek R, et al. Clinical signif- icance of head and neck squamous cell cancer biomarkers. Oral oncology. 2014;50(3):168-

Sciubba JJ. Oral cancer. The importance of ear ly diagnosis and treatment. American journal of clinical dermatology. 2001; 2(4):239-51.

Pontes FS, Carneiro JT, Jr. Fonseca FP, da Silva TS, Pontes HA, Pinto Ddos S, Jr. Squamous cell carcinoma of the tongue and floor of the mouth: analysis of survival rate and independent prog- nostic factors in the Amazon region. The Journal of craniofacial surgery. 2011;22(3):925-30.

Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Koufogiannis D. Management of adenoid cys- tic carcinoma of minor salivary glands. Journal of oral and maxillofacial surgery. 2006;64(7):1114-2.

Silverman S, Jr. Gorsky M. Epidemiologic and de- mographic update in oral cancer: California and national data--1973 to 1985. Journal of the Ameri- can Dental Association (1939). 1990;120(5):495-9.

Gorsky M, Epstein JB, Oakley C, Le ND, Hay J, Stevenson-Moore P. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral surgery, oral medicine, oral pathology, oral radiology, and end- odontics. 2004; 98(5):546-52.

Bell RB, Kademani D, Homer L, Dierks EJ, Potter BE. Tongue cancer: Is there a difference in surviv- al compared with other subsites in the oral cavity? Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2007; 65(2):229-36.

Ramsden D, Sheridan BF, Newton NC, De Wil- de FW. Adenoid cystic carcinoma of the head and neck: a report of 30 cases. The Australian and New Zealand journal of surgery. 1973;43(2):102-8.

Rapidis AD, Givalos N, Gakiopoulou H, Faratzis G, Stavrianos SD, Vilos GA, et al. Adenoid cystic carcinoma of the head and neck. Clinicopatholog- ical analysis of 23 patients and review of the liter- ature. Oral oncology. 2005;41(3):328-35.

Akhlaghi F, Esmaeelinejad M, Shams A, Au- gend A. Evaluation of neo-adjuvant, concurrent and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma: a me- ta-analysis. Journal of dentistry (Tehran, Iran).2014;11(3):290-301.

Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Ar- chives of otolaryngology--head & neck surgery.1999;125(2):149-52.

Maciejewski A, Szymczyk C, Wierzgon J. Out- come of surgery for adenoid cystic carcinoma of head and neck region. Journal of cranio-maxil- lo-facial surgery : official publication of the Euro- pean Association for Cranio-Maxillo-Facial Sur- gery. 2002;30(1):59-61.

Zelefsky MJ, Harrison LB, Fass DE, Armstrong J, Spiro RH, Shah JP, et al. Postoperative radio- therapy for oral cavity cancers: impact of anatom- ic subsite on treatment outcome. Head & neck.1990;12(6):470-5.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.